Effects of isoprenaline and terbutaline on urinary excretion of histamine and its two main metabolites in systemic mastocytosis
- 1 April 1986
- journal article
- clinical trial
- Published by Springer Nature in Inflammation Research
- Vol. 18 (1-2) , 269-272
- https://doi.org/10.1007/bf01988039
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstructionPublished by Elsevier ,1986
- Treatment of two mastocytosis patients with a histidine decarboxylase inhibitorInflammation Research, 1985
- Effect of oral slow-release terbutaline on early morning dyspnoeaEuropean Journal of Clinical Pharmacology, 1985
- Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trialThe American Journal of Medicine, 1985
- Improved Diagnosis of Mastocytosis by Measurement of Urinary Hist Amine MetabolitesNew England Journal of Medicine, 1983
- Intervention with epinephrine in hypotension associated with mastocytosisJournal of Allergy and Clinical Immunology, 1983
- Catecholamine inhibition of rat mast cell histamine secretion — A process independent of cyclic AMP levels and counteracted by glucoseLife Sciences, 1983
- Oral Disodium Cromoglycate in the Treatment of Systemic MastocytosisNew England Journal of Medicine, 1979